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Meta-analysis was used to explore a possible relationship between oral co~t;Ze{tive use and 
women ' s psychological well-being. An analysis of 13 useable studies found a small positive 
effect of oral contraceptive use on women's psychological well-being. However, the meta­
analysis also found great variance among the results of the studies. Possible moderator effects of 
women's health status and history, type of oral contraceptive, or different hormone combinations 
of oral contraceptives could explain these results. However, there were too few useable studies to 
conduct statistical analyses of these possibilities. 
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A Meta-analysis of the Effect of Oral Contraceptive Use 

On Women's Psychological Well-being 

Oral contraceptives are so commonly used and so well known that they have been termed 
simply "the pill." For example, based on a sample of 12,279 female respondents Jones, Mosher, 
and Daniels (2012) reported that almost two thirds of women in the United States used some 
form of contraception between 2006 and 2010; oral contraceptives (OC) were the most common 
form of contraception with 17% of women reporting OC use. Looking to the future, Murphy 
(2006) noted a rise in the demand for more easily accessible oral contraception and given the 
provisions of the Affordable Care Act, which calls for insurers and employers to provide 
contraception in health insurance plans, the demand for ~C's could further increase in the near 
future (Starr, 2013). 
Preventing pregnancy is not a novel concept; through the ages women have used various 
methods to avoid pregnancy. Although recorded instances of contraception date as far back as 
1500 BC Egypt (Chadwick, Burkman, Tomesi, & Mahadevan, 2011), prescribing medication to 
a healthy patient is a more recent idea. As a consequence, carefully weighing the risks and 
benefits of oral contraceptives has been and still is important. For example, Chadwick et ai. 
reported that although risks have been reduced in recent forms of ~C, side effects such as stoke, 
hemorrhagic stroke, myocardial infarction, and deep vain thrombosis are still possible. On the 
other hand, aside from preventing pregnancy, OC is also associated with a long list of benefits 
including menstrual cycle regularity and reductions in acne, functional ovarian cysts, benign 
breast disease, ectopic pregnancy, menstrual blood loss, iron deficiency anemia, and 
dysmenorrhea. Chadwick et ai. concluded newer and more effective forms of OC are 
progressively reducing its physiological risks and its increasing physiological benefits. Although 
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Chadwick et al. conducted a comprehensive review of oral contraception and its physiological 

side effects, they did not address potential psychological side effects . 

How Might Oral Contraceptive Use Affect Psychological Well-being? 

Before examining the literature on psychological side effects, it is important to examine 
the possible mechanisms by which OC might affect psychological well-being. Early researchers 
leaned towards negative societal and personal attitudes toward contraception as possible causes 
of adverse psychological effects (e.g., Weissman & Slaby, 1973 ; Malek-Ahmadi & Behrmarm, 
1976). When researchers began to examine possible pharmacological causes of psychological 
side effects, they focused on depression and its negative correlation with serotonin levels 
(Malek-Ahmadi & Behrmarm, 1976). Two possible mechanisms were proposed for how OC 
affects serotonin. First, OC directly activates tryptophan 2, 3 dioxygenase, converting tryptophan 
into niacin and lowering seratonin; second, estrogen (a main ingredient of ~C) decreases 
serotonin levels by inhibiting pyridoxal phosphate and reducing vitamin B6 (Malek-Ahmadi & 
Behrmarm, 1976). Maleck-Ahmadi and Behrmarm also postulated that progesterone levels in OC 
may affect mood, although the mechanism was unclear. 
As more researchers began to examine the effects of dosage level and composition of OC 
more closely, they discovered additional mechanisms by which OC could cause psychological 
side effects (Kurshan & Epperson, 2005). For example, Rapkin, Biggio, and Concas (2006) 
reviewed the ways in which OC could influence neuroactive steroids levels, noting that the 
hormones active in ~C, mainly estrogen and progestin, decrease production of GABA receptors 
and other nueuroactive steroids. GABA is an inhibitory neurotransmitter that regulates mood, 
sleep, and cognitive functioning; therefore, a decrease in GABA could affect those functions . 
Because some women experience mood stabilization whereas others experience adverse mood 
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changes from OC use, the direction of the effect of GABA inhibition, if any, is unclear. Rapkin 
et al. called for more research to determine if estrogen, progestin, or both reduce GABA 
production. 
Previous Literature Reviews 
Although a computer assisted search did not turn up any previous meta-analyses on the 
relationship of oral contraceptive use to psychological well-being, I found several narrative 
literature reviews. As early as a decade after FDA approval of OC, researchers compiled 
information regarding possible effects of contraception on mood (Weissman & Slaby, 1973). 
Since then, the focus of the research has changed, with early researchers examining OC's 
adverse mood effects and more recent researchers examining its mood-stabilizing effects 
(Weissman & Slaby, 1973; Poromaa & Segebladh, 2011). This section summarizes the findings 
of those previous literature reviews. As will be seen, despite the large amount of research on the 
topic, the results of that research remain inclusive on the possible psychological side effects of 
OC use. 
Early research on the psychological side effects of oral contraceptives. Weissman and 
Slaby (1973) conducted the first review of the research on side effects ofOC use. They observed 
that physicians and the general public had believed that oral contraceptives produced a negative 
effect on women's psychological well-being from the time the FDA approved them in 1960. 
However, the results of research on this question were contradictory. From 1943 to 1966, various 
researchers reported a variety of findings, including a positive association between OC and 
depression, that OC reduced depression, and that a psychological predisposition associated with 
depression developed during OC use. Weissman and Slaby futher noted that studies conducted 
from 1968 to 1971 were also unable to provide evidence of a causal relationship between OC and 
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psychological well-being, specifically depression. Researchers found that OC was associated 
with depression during the first month of use and diminished after that. In 1969, researchers 
concluded that depression during OC use was correlated with previous instances of depression. 
Weissman and Slaby (1973) concluded that the most probable cause of negative psychological 
effects of oral contraceptive use were negative individual and societal attitudes toward OCs; 
when the consumer expected negative psychological side effects, she experienced negative 
psychological side effects. If Weissman and Slaby were correct in this conclusion, the current 
more positive societal attitude of acceptance of contraception would eliminate instances of 
depression and negative affect; however, because depression still occurs during OC use, 
psychological side effects must be pharmacological. 
Based on the findings of their literature review, Malek-Ahmadi and Behrmann (1976) 
agreed with Weissman and Slaby (1973) that any psychological side effects of contraception 
were most likely a result of expectations for negative effects. However, they also noted that oral 
contraceptives could disturb tryptophan metabolism in the central nervous system, decreasing 
serotonin levels, thereby inducing depressive symptoms and that progesterone could contribute 
to occurrence of depression in OC use. Although they acknowledged these possible 
pharmacological mechanisms, Malek-Ahmadi and Behrmann nonetheless suggested that adverse 
psychological effects of OC could result from cultural , religious, societal, or spousal disapproval. 
Further, they suggested that physicians could prevent or alleviate adverse psychological effects 
by inquiring about patients' personality and mental health history before prescribing OC, 
conducting frequent check-ups when an OC user has a history of depression, explaining OC and 
its possible side effects, and prescribing daily doses of 50mg vitamin B6 to offset of possible 
tryptophan metabolism disturbances. 
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Hormones and psychological side effects of oral contraception. Bruce and McCauley 
(1997) focused their literature review on estrogen and progesterone, two components of oral 
contraceptives that are linked to emotional and mental well-being and so may be linked to side 
effects such as depression. They reported that although many studies conducted between 1985 
and 1995 examined possible relations between fluctuating hormone levels and mood across the 
menstrual cycle, none produced conclusive results. They noted that researchers also focused on 
the effect of estrogen and progesterone in oral contraceptives on mood and sexual functioning; 
however, the results of that research were also inconclusive. Bruce and McCauley also pointed 
out a change in the focus of research: although earlier research had suggested a positive 
association between depression and ~C, researchers in the 1980's and early 1990 ' s suggested 
that lower-dose OC might improve pre-existing mood state. That research also suggested that 
although most women do not experience negative affect from low-dose ~C, a minority do 
experience negative affect. In addition, some researchers postulated that negative affect 
experienced during OC use may be the result of a predisposition to depression. Brace and 
McCauley described a 1988 twin study that reported a genetic vulnerability to mood disturbances 
may be involved in OC side effects, although support from research for this hypothesis was 
inconsistent. Brace and McCauley concluded that an association between estrogen, and therefore 
oral contraception, and psychological well-being existed although the strength and direction of 
that association remained inconclusive. 
New millennium research on OC and mood. With the dawn of the new millennium, 
OC research continued to explore the relation of OC use to mood. Oinonen and Mazmanian 
(2002) provided a comprehensive overview of this research that was conducted from 1967 to 
2000. New millennium research proposed that estrogen and progesterone either independently or 
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together affect GABA activity to lower serotonin levels. In addition, progesterone was possibly 
connected with increasing monoamine oxidase (MAO) to reduce serotonin levels in OC users. 
Oinonen et al. classified OC research into categorical and dimensional research : categorical 
research investigated the occurrence of diagnosable mood disorders while dimensional research 
investigated daily mood fluctuation . Categorical research included a large amount of early 
research on OC; as noted earlier, this research variously found that OC increased, decreased, and 
had no effect on depression rates. Dimensional research included the vast majority of more 
recent research. Most of this research did not find a significant relationship between OC use and 
mood, but four studies reported less day to day mood variability in OC users. Oinonen et al. 
concluded that the results of most research indicated a positive psychological effect of OC, but a 
history of depression, moderate to severe premenstrual depression, dysmenorrhea, or postpartum 
depression could put women at risk for negative psychological side effects of OC use, such as 
depression. Although previous research syntheses had concluded that OC mood effects resulted 
from negative expectations, Oinonen et al. cited a 1971 study that refuted that possibility. 
Oinonen and Mazmanian (2002) also reported results of the effects of different OC 
dosages. The research they examined showed that high doses of OC were associated with 
adverse mood effects. Progesterone dosage, in particular, appeared to be related to mood; high 
doses negatively affected mood, low doses also negatively affected mood in women with a 
history of PMS, and higher doses of progesterone relative to estrogen dosages produced negative 
mood effects. In addition, monophasic OC tended to have mood stabilization effects whereas 
triphasic OC was more likely than mono- or bi-phasic OC to produce adverse mood effects. 
Monophasic OC referes to pills that administer the same dosage of hormones throughout the 
menstrual cycle while biphasic and triphasic oral contraceptives change the dosage of hormones 
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once and twice respectively during a menstrual cycle. Oinonen et al. reported that a major flaw in 
research on the relation between OC and mood was the "survivor effect" in which women who 
experience negative psychological effects stop taking ~C, resulting in an underestimation of 
mood effects. Oinonen et al. concluded that research did not eliminate the possibility of indirect 
roots for psychological side effects, such as expectations of mood change, guilt or security about 
preventing childbirth, and mood change resulting from physical side effects. 
Although indirect causes of psychological side effects are a possibility, Poromaa and 
Segebladh (2011) concluded from their literature review that research supported the presence of 
more positive than negative psychological side effects. A change in OC ingredients from 
progesterone to drospirenone and desogestrel appeared to have resulted in fewer adverse 
psychological side effects. In addition, lower doses of ethinyl estradiol (EE)/levenonorgestrel 
may be less likely to cause negative mood and more likely to have positive mood effects than 
higher doses or progesterone-only OCs. Poromaa and Segebladh also found that low socio­
economic status African American women who used OC experienced higher levels of positive 
mood and lower levels of negative mood during stable OC use compared to less pronounced 
variability in mood during intermittent OC use. In addition, Poromaa and Segelbladh found that 
mood variability appeared to be correlated with the menstrual cycle: adverse mood was more 
likely to occur during the pill-free interval and more positive mood during the menstrual and 
premenstrual phases. Poromaa and Segelbladh, unlike Oinonen and Mazmanian (2002), 
concluded that OC may benefit women with premenstrual dysphoric disorder and possibly 
women with major depression, but that fUl1her research was needed. 
Oral contraceptives, mood, and premenstrual dysphoria. Kurshan and Epperson 
(2005) reviewed research on OC mood effects on women with premenstrual dysphoria (PMDD). 
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They found that research conducted from 1972 to 2003 offered more support for OC alleviating 
adverse mood effects than for producing adverse mood effects. The introduction of more 
androgenic ingredients such as drospirenone into OC and of newer progestins may have 
accounted for the shift from adverse to positive mood effects and so these newer formulations 
may be beneficial to women with PMDD: however, Kurshan and Epperson thought that the 
results of the research were inconclusive on that point. Like Oinonen and Mazimanian (2002), 
Kurshan and Epperson reported that triphasic OC resulted in more adverse mood effects than 
monophasic OC in women with PMS symptoms. Therefore, more androgenic doses of OC could 
be helpful to both healthy women and those with a history of PMDD and PMS symptoms. 
Kurshan and Epperson concluded that OC is not associated with adverse psychological effects in 
healthy women, although subgroups may experience negative mood effects. 
Conclusions. During the history of research on the relationship between oral 
contraceptive use and mood, the focus has shifted from adverse mood effects to positive mood 
effects and to whether adverse mood effects differ for different groups of women, such as 
members of different ethnic/racial minority groups. Changes in the formulation of OC, such as 
including more androgynous ingredients and lower hormone dosages, accounted for most of that 
shift in research focus. Research reviewers agreed that monophasic contraceptives result in less 
adverse psychological effects than biphasic contraceptives and biphasic contraceptives result in 
less severe psychological effects than triphasic contraceptives. Women with a predisposition for 
mood disorders, PMDD, or severe PMS symptoms appear to be at higher risk for adverse mood 
symptoms with most OCs. Further research is needed to determine whether other subsets of 
women have higher risk of adverse psychological effects, the severity of their increased risk, and 
any conclusive effects of OC on psychological well-being. 
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The Current Research 
The research discussed above has examined general trends and limitations in oral 
contraceptive use and psychological well-being. However, prior literature reviews have been 
qualitative and so have not quantitatively addressed such issues as effect sizes and moderator 
variables . In addition, some of the research reviews did not include all of the available research 
articles. The current study will take the form of a meta-analysis calculating effect sizes and 
examining the roles of moderator variables. This approach permits a more comprehensive 
analysis of the effects of contraceptive use on psychological well-being. 
Hypotheses 
Considering past research, hypotheses on the relationship between oral contraceptive use 
and psychological well-being will hinge on oral contraceptive dosage and ingredients and 
specific populations of women. Monophasic contraceptives will have the least adverse 
psychological effects followed by biphasic contraceptives with triphasic contraceptives being 
most harmful. In addition, newer combination oral contraceptives will be associated with more 
positive psychological effects while progesterone- or estrogen-only contraceptives will be 
associated with more negative psychological effects. Lastly, women with a predisposition to a 
mood disorder, PMDD, severe PMS symptoms, and women who smoke will be at higher risk for 
adverse psychological effects. 
Method 
Sample of Studies 
Only published studies were included in the meta-analysis. Research articles were 
collected by searching PsycINFO and Medline using the search terms contracept* and (well­
being, depress*, and mood) in which "*,, is a truncation character that institutes a search for any 
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word having the designated stem. Additional articles were located using the reference lists of 
research articles identified in PsycINFO, MedLine, and previous literature reviews. Research 
studies were included that listed psychological well-being or mood as a primary or secondary 
outcome. Only studies using human participants conducted since the year 2000 were included. 
Studies were excluded that are no longer available or are in a language other than English. 
Coding the Studies 
Studies were coded on the following variables: organization sponsoring the study, 
whether the study was externally funded, whether mood was the primary focus of the research, 
sample size, randomization, where participants were recruited, country where the study was 
conducted, demographics (SES, age, race), any shared medical history of participants, OC 
ingredients and dosage, length of study, categorical or dimensional study, what scales were used 
to asses the dependent variables, what kind of experiment, statistical analysis, p-value, control 
group, placebo, attrition rate, reasons for attrition, results, and limitations and strengths. 
Statistical Analysis 
Hedge's d was used to estimate the effect size of the relationship between oral 
contraceptive use and psychological well-being. A positive effect size resembled an 
improvement of psychological well-being with contraceptive use. Conversely, a negative effect 
size resembled an impairment of psychological well-being with contraceptive use. Standard 
deviations, means, and t-values were converted to d using Rosenthal (1994) formulas. Hedges 
and Becker's (1986) formulas were used for calculating weighted effect size, confidence 
intervals, and mean effect size comparisons. The equivalent Pearson's r was also calculated for 
mean effect sizes. 
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Results 
Initial database searches located 64 studies with relevant titles and abstracts. Fifty-one of 
those studies were excluded due to lack of a control condition (n = 36), insufficient data to 
calculate effect size (n = 7), the study's measured assessed variables such as jealousy (n = 1) or 
personality (n = 2), the study assessed menstrual symptoms only (n = 2), or the study was 
unavailable (n = 3). The remaining 13 studies included a total sample of 2,483 women. Only one 
hypothesis could be tested through meta-analysis due to lack of available studies. No sub­
analyses could be performed so the hypotheses that monophasic contraceptives and combination 
estrogen and progesterone contraceptives would have less adverse effects than biphasic, 
triphasic, and single hormone contraceptives could not be tested. In addition, the hypothesis that 
women with PMDD, severe PMS, a mood disorder, or women who smoke would be at higher 
risk for adverse psychological effects could not be tested. The hypothesis that oral contraceptives 
would generally have a small positive relationship with psychological well-being was tested. 
Table 1 lists the sample sizes and calculated effect sizes for these studies. 
For the hypothesis that oral contraceptive use would have a slight positive effect on 
psychological well-being, the mean effect size (d) of the 13 useable studies was 0.151 (r = 
0.075), z = 5.288, p < .0001, supporting the hypothesis. The index of variance of effect sizes (Q) 
was 48 .808, df= 12,p < .001, indicating a large degree of variance among the effect sizes of the 
studies. Among the l3 useable studies, three (Gringnell et aI., 20l3; Kulkarni, 2007; Oinonen & 
Mazmanian, 2001) were identified as outliers because, unlike other studies, they had negative 
effect sizes. When these outliers were removed, the mean effect size did not change to a 
meaningful degree, d = 0.183, r = 0.091, z = 6.189, p < .0001; Q = 29.733, df= 9, p < .001. 
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Table I 
Effect Sizes ofStudies Included in the Meta-Analysis 
Study Sample Size Effect Size ( dt 
Abraham et aI. , 2003 72 0.230 
Atkin et aI. , 2010 210 0.000 
Freeman et aI., 2001 82 0.314 
Gringnell et a!., 2013 34 -0.493 
Halbreich et ai., 2012 274 0.295 
Kulkarni , 2007 58 -0 .392 
Natale & Albertazzi, 2006 62 0.423 
Oinonen & Mazmanian, 79 -0.130 
2002 
Pearlstein et aI. , 2005 32 0.849 
Segebladh et aI., 2009 118 0.056 
Svendal et ai., 2012 498 0.165 
Yonkers et ai. , 2005 449 0.358 
Young et ai. , 2007 515 0.000 
aA positive effect size indicates a positive effect of oral contraceptive use on women's 
psychological well-being. 
Discussion 
Because of the small number of useable studies, the hypotheses that monophasic and 
combination estrogen and progesterone oral contraceptives would have less adverse 
psychological effects than biphasic, triphasic, and single hormone oral contraceptives could not 
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be tested. Similarly, the hypothesis that women with a mood disorder, PMDD, severe PMS, or 
who smoke would be at higher risk for adverse psychological effects could not be tested. The 
results of the meta-analysis supported the hypothesis that oral contraceptive use would have a 
small positive relationship with psychological well-being. The mean effect size showed a small 
statistically significant positive effect of oral contraceptive use on women's psychological well­
being. However, there was also statistically significant variance among the results of the studies; 
studies varied from large positive to large negative effect sizes. When the three studies with 
negative sizes were excluded from the calculation, the overall effect size did not change to a 
meaningful degree, so the presence of negative outliers did not account for the small mean effect 
size. However, the effects of possible moderator effects could be a reason for the variance in 
effect sizes. 
One such possible moderator is the health status of the women who participated in 
different studies. For example, Freeman et al. (2001), Halbreich et a1. (2012), Pearlstein, 
Bachmann, Zacur, and Yonkers (2005), and Yonkers et a1. (2005) included samples of women 
suffering from PMDD and had slightly larger positive effect sizes than studies including other 
samples of women (d = 0.314, d = 0.295, d = 0.849, d = 0.358, respectively). Gingnell et a1. 
(2013) found the largest negative effect size at -0.493 and included women who had previously 
discontinued oral contraception due to adverse mood effects. Young et a1. (2007), whose sample 
consisted of women diagnosed with non-psychotic major depressive disorder, found a near zero 
effect size. However, the small number of studies in each category precluded a statistical analysis 
of these differences. 
The results of research of the relation between OC use and mood might also be affected 
by women's prior experience with contraception or their medical histories. For example, 
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Gingnell et aI.' s (2013) results indicated that certain subgroups of women may be predisposed to 
adverse mood reactions from oral contraceptive use. Gingell et al. found that women with who 
had previously discontinued OC use due to adverse reactions were likely to experience adverse 
mood reactions again upon resuming usage. Based on fMRI imagery, the researchers found that 
left insula reactivity increased in women using OC, which may be indicative of depressed mood 
and increased anxiety. However, these women's adverse mood reactions could also be due to 
their anticipation of adverse reactions. In addition, Oinonen and Mazmanian (2001) found that 
there might be an interaction between mood stability during OC use and women ' s 
medical/family history. However, these were weak interactions and the findings were 
exploratory. Therefore, no firm conclusions can be drawn from the results of this study. 
Another possible moderator variable could be type of OC that women use. However, my 
meta-analysis did not permit examination of this possibility because the useable studies 
examined only combined oral contraceptives. Young et al. (2007) did examine the effects of a 
progesterone-only contraceptive, but that study did not have a placebo or appropriate 
contraception use comparison condition so it was not possible to evaluate the effects of different 
types ofOC. 
Finally, the formulation of different combinations OCs in terms of the combinations of 
hormones included in them could act as a moderator variable. There was too much variability of 
hormone combinations among studies to do sub-analysis on this possibility. However, 
drospirenone and levonorgestrel, two common synthetic progesterone hormones, may have 
differing effects on psychological well-being. Several groups of researchers (Abraham, 
Luscombe, & Soo, 2003; Akin, Ege, Aksullu, Demiroren, & Erdem 2010; Gingnell et ai, 2013; 
Halbreich et aI., 2012) included contraceptives made with levonorgestrel and found effect sizes 
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that ranged from -0.493 to 0.295. Freeman et al. (2001), Pearlstein et al. (2005), and Yonkers et 
al. (2005) included contraceptives using drospirenone and had effect sizes that ranged from 
0.314 to 0.849. Although the studies including drospirenone had larger positive effect sizes, 
these studies also included women suffering from PMDD. Therefore the larger positive effect 
size could be due to either variable. 
Limitations 
This meta-analysis had a various limitations. First, my meta -analysis had a very small 
sample of useable studies, which affects the generalizability of results. In addition, the useable 
studies were too different in regards to conditions included and too few in number to do further 
sub-analysis investigating the effects of possible moderator variables. Third, this study had only 
one researcher collecting and coding studies, could have led to bias because there was not way to 
evaluate the reliability of the codings. Finally, the terms used to search databases may not have 
been all-inclusive so that some potentially useable studies could have been overlooked. 
Conclusions 
My meta-analysis was unable to draw any firm conclusions about a relationship between 
oral contraceptive use and psychological well-being. There was a significant small positive 
relationship, but the significant large variance means the small positive relationship is not 
consistent. The large number of studies that had to be excluded, especially for a lack of a 
controlled condition or poor methodology, was concerning. There were too few studies and 
many studies were too poorly designed to provide much understanding of what happens to 
women's psychological well-being when they use oral contraceptives. Future contraceptive 
research should always use a control condition and collect data both daily and at intervals of 
treatment in order to better understand the effects of oral contraception. 
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